Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 29

Page
per page
  1. XMU-MP-1
    A8735 XMU-MP-1
     2 Citation
    Target: MST
    Summary: MST1/2 inhibitor, potent and selective
      ≥41.6 mg/mL
  2. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  3. SB 216763
    A8240 SB 216763
     3 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor,ATP-competitive,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥56.8 mg/mL
  4. GANT61
    A1615 GANT61
     1 Citation
    Target: GLI
    Summary: GLI antagonist
  5. Verteporfin
    A8327 Verteporfin
    Target: YAP
    Summary: Photosensitizer used in photodynamic therapy
      insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL
  6. CHIR-98014
    A8395 CHIR-98014
    Target: GSK-3
    Summary: GSK-3β inhibitor,selective and ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥8.1 mg/mL
  7. LY2940680
    A8651 LY2940680
    Target: Smoothened receptor
    Summary: Hedgehog/SMO antagonist,inhibits Hh signaling
  8. Wnt-C59
    A8685 Wnt-C59
     2 Citation
    Target: PORCN
    Summary: PORCN inhibitor,highly potent and selective
      .95 mg/mL
      insoluble in H2O; ≥18
  9. IWP-L6
    B2305 IWP-L6
    Summary: Porcupine inhibitor,highy potent
      ≥22.45 mg/mL
  10. FH535
    A3413 FH535
    Summary: Wnt/B-catenin inhibitor
      ≥36.1 mg/mL

Items 1-10 of 29

Page
per page